The Computational Neurogenomics Laboratory

We are a team of scientists on a mission to advance understanding of Parkinson’s disease and neuropsychiatric disorders through genomics and data science.

Miguel Rentería

Associate Professor Miguel Rentería

Group Leader

The Computational Neurogenomics Laboratory - DNA sequence

Research Focus

At the Computational Neurogenomics Laboratory, we work at the intersection of human genetics, data science, digital biomarkers, and brain health. Our research focuses on understanding the genetic and molecular foundations of complex brain-related traits and diseases, particularly Parkinson’s disease (PD).

We are building world-leading resources by integrating genomics, neuroimaging, wearable-derived digital biomarkers, and electronic health data to accelerate discoveries in disease prediction, progression, and personalised care.

We lead major national and international initiatives such as the Australian Parkinson’s Genetics Study (APGS), now the largest PD genetics cohort in Australia, and collaborate globally through programs like the Global Parkinson’s Genetics Program (GP2), the Psychiatric Genomics Consortium (PGC), and the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium.

Our work combines big data analysis, statistical genomics, and translational science to uncover the biological drivers of clinical heterogeneity and to develop real-world tools to monitor and predict disease progression.

Gallery

Brain structure and neurodegeneration
Brain structure and neurodegeneration
The Computational Neurogenomics Laboratory
Computational Neurogenomics Team
Nature Genetics Cover - November 2024
Nature Genetics Cover - November 2024
Computational Neurogenomics Team
Computational Neurogenomics Team
Wearable technology to monitor health and disease
Wearable technology to monitor health and disease
Global Parkinson's Genetics Program Meeting, Annual Investigators Meeting - Kuala Lumpur, 2024
Global Parkinson's Genetics Program Meeting, Annual Investigators Meeting - Kuala Lumpur, 2024

Research Projects

Current Research Projects

The Australian Parkinson’s Disease Study: From GWAS to Treatment

Monogenic Parkinson’s Disease Australia Initiative (MonoPDAus Initiative): Towards a Precision Medicine Approach

Characterising the genetic architecture of polygenic conditions, including Parkinson’s disease, Alzheimer’s disease, sleep apnoea, acne, self-harm behaviours, chronic pain, depression, and others


Research Team

Luis García-Marín

Dr Luis García-Marín

Natalia Ogonowski

Dr Natalia Ogonowski

Santiago Diaz-Torres

Dr Santiago Diaz-Torres

Freddy Chafota

Dr Freddy Chafota


Funding

  • Rebecca L Cooper Medical Research Foundation, Australia
  • National Health and Medical Research Council, Australia
  • Medical Research Future Fund, Australia
  • The Michael J. Fox Foundation for Parkinson’s Research, USA
  • Shake It Up Australia Foundation, Australia
  • IMPACT Philanthropy Funding, Perpetual Ltd, Australia
  • National Institute of Mental Health, USA
  • American Parkinson’s Disease Association, USA
  • Alzheimer’s Association, USA

Selected publications

Hibar DP*, Stein JL*, Rentería ME*, ... [256 coauthors], Thompson PM & Medland, SE (2015). Common genetic variants influence human subcortical brain structures. Nature, 520, 224-229. https://doi.org/10.1038/nature14101

Campos AI, García-Marín LM, Byrne EM, Martin NG, Cuéllar-Partida G & Rentería ME (2020). Insights into the aetiology of snoring from observational and genetic investigations in the U.K. Biobank. Nature Communications, 11[1], 817. https://doi.org/10.1038/s41467-020-14625-1

Campos AI, Thompson PM, Veltman DJ, ... [54 coauthors], Schmaal L & Rentería ME (2021). Brain correlates of suicide attempt in 18,925 participants across 18 international cohorts. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2021.03.015

Read More

Further Information


Past Researchers
  • Adrián I. Campos, PhD, UQ Australia (2018-2021)
  • Brittany L. Mitchell, PhD QUT Australia (2018-2021)
  • Dulari J. Lekamlage, PhD, QUT Australia (2019-2022)
  • Luis M. García-Marín, PhD, UQ Australia (2021-2024)
  • Asma M. Aman, Masters, LMU Munich Germany (2021)
  • Xóchitl Díaz-Téllez, BSc, UNAM Mexico (2023-2024)


External Collaborations
  • Adam Vogel, University of Melbourne Australia
  • Adrián Zegarra-Valdivia, Señor de Sipán University Peru
  • Alejandra Medina-Rivera, UNAM Mexico
  • Alejandra Ruiz Contreras, UNAM Mexico
  • Alexis Edwards, Virginia Commonwealth University USA
  • Athula Sumathipala, IRD Colombo, Sri Lanka
  • Carlos Cruz, National Psychiatry Institute Mexico
  • Dale Nyholt, QUT Australia
  • Gabriela Martinez, National Psychiatry Institute Mexico
  • George Mellick, Griffith University Australia
  • Ignacio Mata, Cleveland Clinic USA
  • Jennifer Yokoyama, UCSF USA
  • Jill Rabinowitz, Rutgers University USA
  • Joyce Wang, Sun Yat-Sen University China
  • Kishore Kumar, Garvan Institute Australia
  • Lianne Schmaal, Orygen & Uni of Melbourne Australia
  • Michael Simpson, King's College London USA
  • Paul Thompson, University of Southern California USA
  • Sarael Alcauter, UNAM Mexico
  • Xianjun Dong, Yale University USA

International Consortia: